What is the State of Clinical Trial Patient Matching Right Now?

Balancing Innovation and Practicality in Immuno-Oncology Dose Selection

Leveraging Local HCPs to Decentralize Clinical Research in North Carolina

Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes

What to Expect at the 2026 Patients as Partners in Clinical Research Conference

The Role of the CMO in BD and M&A Partnering with Pharma

Advances in Payload Delivery and Drug Conjugation

Building Up a CMO Team as Your Company Evolves

Beyond LNPs: Delivering Genetic Medicines with Novel Vehicles

Pfizer on Advancing Data Analysis Capabilities through A New EDC/CDMS Platform

Insights from Tufts CSDD into Evolving Trial Partnerships Models

ADCs, Chemotherapy, and Checkpoint Blockade in Urothelial Carcinoma

Understanding the Immunological Effects of Radiopharmaceuticals

How J&J Is Integrating Patient Centricity Across the Enterprise

Biogen's Nicole Murphy on Drug Delivery Innovation and the Acquisition of Alcyone Therapeutics

What to Expect at the 2026 IO360° Summit

CMOs Working Flexibly with Consultants and Fractional Expertise

Principles and Strategies for Designing Best-in-Class Immuno-Oncology ADCs

How Patient Organizations are Bridging Patient Inclusivity Gaps at the Site-Level

How Roche Reduced Unnecessary Protocol Amendments to Impact Timeline and Cost